News Focus
News Focus
Followers 49
Posts 5473
Boards Moderated 0
Alias Born 04/30/2005

Re: Hoskuld post# 469449

Friday, 09/13/2024 11:18:48 AM

Friday, September 13, 2024 11:18:48 AM

Post# of 518868
Hoskuld...You asked me: What would lead you to believe that Dr. Kun Jin designed the P2 schizo trial using 3-71?

Very simple. He is probably the most experienced person on their staff...and he has successfully designed other trials. (See below)

"During his [25 years] tenure at the agency, Dr. Jin has contributed extensively to statistical review issues and trial designs surrounding the regulatory approval of drugs for the treatment of neurological diseases including Alzheimer’s disease, Parkinson’s disease, migraine, epilepsy, and multiple sclerosis, as well as rare diseases, such as ALS and DMD."

So, let me ask you a question. Why would you conclude that "he totally was not "the one that designed the trial"?

Additionally, you were incorrect to insinuate that Dr. Kun Jin is somehow responsible for designing the failed P3 Rett trial for pediatrics. Why would you insinuate that?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News